Field Medical Names Mark A. Turco as Chief Executive Officer

Field Medical Mark A Turco CEO appointment signals a major leadership move in the medtech sector, as Field Medical announced that Dr. Mark A. Turco has been named Chief Executive Officer, effective immediately. The company is focused on advancing next-generation pulsed field ablation (PFA) solutions for treating complex cardiac arrhythmias.

Dr. Turco brings more than three decades of leadership experience across cardiovascular startups and global medical device organizations. His background combines clinical expertise as an interventional cardiologist with extensive executive experience in guiding companies through development, regulatory milestones, and commercialization.

Experienced Leadership to Accelerate Innovation

Throughout his career, Dr. Turco has led multiple clinical-stage companies and played a key role in strategic transactions. Most notably, he served as President and CEO of JC Medical, where he oversaw the development of a transcatheter aortic valve replacement (TAVR) system that was later acquired by Edwards Lifesciences.

He has also held senior leadership positions at major healthcare companies, including Medtronic and Covidien, where he contributed to advancing vascular and neurovascular technologies.

Supporting Field Medical’s Next Growth Phase

Field Medical is currently focused on expanding its clinical programs and advancing its proprietary PFA platform, designed to improve treatment outcomes for patients with ventricular and atrial arrhythmias.

The company’s FieldForce Ablation System integrates a unique catheter design with advanced energy delivery technology to provide precise and efficient ablation therapy.

With Dr. Turco’s appointment, the company aims to strengthen its operational capabilities and accelerate progress across clinical development and regulatory pathways.

Combining Clinical Insight with Operational Expertise

Dr. Turco’s dual background in medicine and executive leadership positions him to guide Field Medical through its next stage of innovation. His experience as a board-certified cardiologist provides a deep understanding of patient needs, while his industry leadership brings strategic and operational discipline.

In his statement, Dr. Turco emphasized the potential of Field Medical’s technology to address unmet needs in cardiac care and expressed his commitment to advancing the company’s clinical programs.

Advancing the Future of Cardiac Care

The appointment reflects Field Medical’s broader ambition to scale its technology and deliver next-generation solutions in cardiac treatment. As demand grows for more effective and minimally invasive therapies, pulsed field ablation is emerging as a promising approach in the field of electrophysiology.

With new leadership in place, Field Medical is positioning itself to accelerate innovation, expand its clinical footprint, and bring advanced treatment options to patients worldwide.

CXO Insiders is a platform for C-suite leaders, offering expert insights, industry trends, and strategic guidance. It covers leadership, technology, marketing HR and operations to support executive decision-making.

Read related news - https://cxoinsiders.com/copperpoint-names-mark-woods-svp-head-of-product/